Cardiac-specific deletion of voltage dependent anion channel 2 leads to dilated cardiomyopathy by altering calcium homeostasis

被引:0
|
作者
Thirupura S. Shankar
Dinesh K. A. Ramadurai
Kira Steinhorst
Salah Sommakia
Rachit Badolia
Aspasia Thodou Krokidi
Dallen Calder
Sutip Navankasattusas
Paulina Sander
Oh Sung Kwon
Aishwarya Aravamudhan
Jing Ling
Andreas Dendorfer
Changmin Xie
Ohyun Kwon
Emily H. Y. Cheng
Kevin J. Whitehead
Thomas Gudermann
Russel S. Richardson
Frank B. Sachse
Johann Schredelseker
Kenneth W. Spitzer
Dipayan Chaudhuri
Stavros G. Drakos
机构
[1] University of Utah,Nora Eccles Harrison Cardiovascular Research and Training Institute
[2] University of Utah,Department of Biomedical Engineering
[3] LMU Munich,Walther Straub Institute of Pharmacology and Toxicology, Faculty of Medicine
[4] University of Connecticut,Department of Kinesiology
[5] Salt Lake City VA Medical Center,Geriatric Research, Education, and Clinical Center
[6] Ludwig-Maximilians Universität Munich,Walter
[7] German Centre for Cardiovascular Research (DZHK),Brendel
[8] Partner Site Munich Heart Alliance,Center of Experimental Medicine
[9] University of California,Department of Chemistry and Biochemistry
[10] Memorial Sloan Kettering Cancer Center,Division of Cardiovascular Medicine
[11] University of Utah School of Medicine,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Voltage dependent anion channel 2 (VDAC2) is an outer mitochondrial membrane porin known to play a significant role in apoptosis and calcium signaling. Abnormalities in calcium homeostasis often leads to electrical and contractile dysfunction and can cause dilated cardiomyopathy and heart failure. However, the specific role of VDAC2 in intracellular calcium dynamics and cardiac function is not well understood. To elucidate the role of VDAC2 in calcium homeostasis, we generated a cardiac ventricular myocyte-specific developmental deletion of Vdac2 in mice. Our results indicate that loss of VDAC2 in the myocardium causes severe impairment in excitation-contraction coupling by altering both intracellular and mitochondrial calcium signaling. We also observed adverse cardiac remodeling which progressed to severe cardiomyopathy and death. Reintroduction of VDAC2 in 6-week-old knock-out mice partially rescued the cardiomyopathy phenotype. Activation of VDAC2 by efsevin increased cardiac contractile force in a mouse model of pressure-overload induced heart failure. In conclusion, our findings demonstrate that VDAC2 plays a crucial role in cardiac function by influencing cellular calcium signaling. Through this unique role in cellular calcium dynamics and excitation-contraction coupling VDAC2 emerges as a plausible therapeutic target for heart failure.
引用
收藏
相关论文
共 37 条
  • [1] Cardiac-specific deletion of voltage dependent anion channel 2 leads to dilated cardiomyopathy by altering calcium homeostasis
    Shankar, Thirupura S.
    Ramadurai, Dinesh K. A.
    Steinhorst, Kira
    Sommakia, Salah
    Badolia, Rachit
    Krokidi, Aspasia Thodou
    Calder, Dallen
    Navankasattusas, Sutip
    Sander, Paulina
    Kwon, Oh Sung
    Aravamudhan, Aishwarya
    Ling, Jing
    Dendorfer, Andreas
    Xie, Changmin
    Kwon, Ohyun
    Cheng, Emily H. Y.
    Whitehead, Kevin J.
    Gudermann, Thomas
    Richardson, Russel S.
    Sachse, Frank B.
    Schredelseker, Johann
    Spitzer, Kenneth W.
    Chaudhuri, Dipayan
    Drakos, Stavros G.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [2] Cardiac-specific Deletion Of Voltage Dependent Anion Channel 2 Leads To Dilated Cardiomyopathy By Altering Calcium Homeostasis
    Shankar, Thirupura S.
    Ramadurai, Dinesh Kumar Anandamurugan
    Steinhorst, Kira
    Sommakia, Salah
    Badolia, Rachit
    Krokidi, Aspasia Spyridoula Thodou
    CIRCULATION RESEARCH, 2021, 129
  • [3] Development of dilated cardiomyopathy and impaired calcium homeostasis with cardiac-specific deletion of ESRRβ
    Rowe, Glenn C.
    Asimaki, Angeliki
    Graham, Evan L.
    Martin, Kimberly D.
    Margulies, Kenneth B.
    Das, Saumya
    Saffitz, Jeffery
    Arany, Zoltan
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2017, 312 (04): : H662 - H671
  • [4] Cardiac-specific Deletion of Orai3 Channel Causes Dilated Cardiomyopathy
    Mancarella, Salvatore
    Kamatham, Samuel
    CIRCULATION RESEARCH, 2019, 125
  • [5] Cardiac-Specific Deletion of Orai3 Leads to Severe Dilated Cardiomyopathy and Heart Failure in Mice
    Gammons, Jesse
    Trebak, Mohamed
    Mancarella, Salvatore
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (08):
  • [6] Cardiac-specific Deletion Of Desmoplakin Causes Dilated Cardiomyopathy And Remodeling Of Gap Junctions
    Hames, Kiyomi Yamada
    Asimaki, Angeliki
    Habib, Nicole
    Saffitz, Jeffrey E.
    CIRCULATION, 2008, 118 (18) : S284 - S284
  • [7] Cardiac-specific Deletion of GSK-3α and GSK-3β Leads to Fatal Dilated Cardiomyopathy With Mitotic Catastrophe
    Zhou, Jibin
    Ahmad, Firdos
    Lal, Hind
    Parikh, Shan
    Hoffman, Nichole E.
    Rajan, Sudarsan
    Shanmughapriya, Santhanam
    Zhang, Xiaoxiao
    Guo, Yuanjun
    Yuan, Ancai
    Song, Jianliang
    Chen, Xiongwen
    Madesh, Muniswamy
    Woodgett, James R.
    Kishore, Raj
    Force, Thomas L.
    CIRCULATION, 2014, 130
  • [8] An Adult Mouse Model of Dilated Cardiomyopathy Caused by Inducible Cardiac-Specific Bis Deletion
    Yun, Hye Hyeon
    Jung, Soon Young
    Park, Bong Woo
    Ko, Ji Seung
    Yoo, Kyunghyun
    Yeo, Jiyoung
    Kim, Hong Lim
    Park, Hun Jun
    Youn, Ho Joong
    Lee, Jeong Hwa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (03) : 1 - 9
  • [9] Cardiac-specific ablation of Cypher leads to a severe form of dilated cardiomyopathy with premature death
    Zheng, Ming
    Cheng, Hongqiang
    Li, Xiaodong
    Zhang, Jianlin
    Cui, Li
    Ouyang, Kunfu
    Han, Liang
    Zhao, Ting
    Gu, Yusu
    Dalton, Nancy D.
    Bang, Marie-Louise
    Peterson, Kirk L.
    Chen, Ju
    HUMAN MOLECULAR GENETICS, 2009, 18 (04) : 701 - 713
  • [10] Cardiac-Specific Cre Induces Age-Dependent Dilated Cardiomyopathy (DCM) in Mice
    Rehmani, Taha
    Salih, Maysoon
    Tuana, Balwant S.
    MOLECULES, 2019, 24 (06):